AI assistant
Moderna, Inc. — Director's Dealing 2025
Feb 28, 2025
30610_dirs_2025-02-28_8f79fee7-eff0-4fb2-a616-4b5513d5caef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-02-27
Reporting Person: Mock James M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-27 | Common Stock | M | 1326 | — | Acquired | 13065 | Direct |
| 2025-02-27 | Common Stock | F | 642 | $33.58 | Disposed | 12423 | Direct |
| 2025-02-27 | Common Stock | M | 3094 | — | Acquired | 15517 | Direct |
| 2025-02-27 | Common Stock | F | 1496 | $33.58 | Disposed | 14021 | Direct |
| 2025-02-27 | Common Stock | M | 1326 | — | Acquired | 15347 | Direct |
| 2025-02-27 | Common Stock | F | 642 | $33.58 | Disposed | 14705 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-27 | Performance Stock Units | $ | M | 1326 | Disposed | Common Stock (1326) | Direct | |
| 2025-02-27 | Restricted Stock Units | $ | M | 3094 | Disposed | Common Stock (3094) | Direct | |
| 2025-02-27 | Restricted Stock Units | $ | M | 1326 | Disposed | Common Stock (1326) | Direct |
Footnotes
F1: Performance stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units.
F3: Restricted stock units convert into common stock on a one-for-one basis.
F4: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F5: 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025.
F6: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F7: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.